GRINN’s story is one of a dream realized through perseverance and vision. It’s a tale of entrepreneurial resilience and the relentless pursuit of excellence. The journey was not always easy, but it was marked by unwavering courage and commitment.

Clarissa Rodrigues, the founder, has a strong background in scientific research, beginning with a Cardiology residency and advanced degrees, including work at Duke University and Stanford University. Upon returning to Brazil, she applied her expertise at a leading cardiology institution, introducing international practices and founding a department for real-world data studies.

Clarissa’s entrepreneurial spirit came to life at the MEDICA Fair in Germany, where GRINN began to take shape, driven by industry needs and evolving regulations. In May 2022, GRINN formed strategic partnerships with industry leaders, enhancing its market position and expanding services to meet specialized client needs.

In 2024, GRINN took a bold step by opening an office in San Francisco, California, marking a significant milestone in its journey and reinforcing its commitment to global growth and collaboration.

Today, GRINN is recognized for its innovative clinical research solutions, serving a global network with a strategic, technology-driven approach.